Skip to content

Market capitalization at other companies

Pfizer logo
PfizerPFE
$159.73B+11.1%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$2.06B+95.0%
AbbVie logo
AbbVieABBV
$384.69B+3.8%
Immunome logo
ImmunomeIMNM
$2.47B+323%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$2.71B+226%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$6.25B+816%

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$9.3M-52.6%
Net income-$8.4M-44.6%
EPS (diluted)-$0.05+28.6%

Balance sheet

See full
Cash & equivalents$107.1M+277%
Total debt$871.0K+0.1%
Total equity$107.4M+287%
Total assets$114.2M+227%

Cash flow

See full
Operating cash flow-$8.8M+2.5%

Valuation

See full
Enterprise value$1.68B+826%

Profitability

See full
Gross margin90%-7.4pp
Operating margin-4,195%-4,591pp
Net margin-4,130.1%-4,444pp
FCF margin-300.5%

Returns & leverage

See full
Return on equity-43.6%-17.9pp
Debt / equity0.0×
Current ratio17.2×+12.6×

Where this comes from

Computed from the period-end share price: $759.63M.

The official record: SELLAS Life Sciences Group, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about SELLAS Life Sciences Group, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SELLAS Life Sciences Group, Inc.'s market capitalization?
SELLAS Life Sciences Group, Inc. (SLS) reported market capitalization of $759.63M in Q1 2026.
How has SELLAS Life Sciences Group, Inc.'s market capitalization changed year-over-year?
SELLAS Life Sciences Group, Inc.'s market capitalization increased by 674.2% year-over-year, from $98.11M to $759.63M.
What is the long-term trend for SELLAS Life Sciences Group, Inc.'s market capitalization?
Over 5 years (2020 to 2025), SELLAS Life Sciences Group, Inc.'s market capitalization has grown at a 42.2% compound annual growth rate (CAGR), from $92.29M to $537.01M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.